États-Unis · Plateformes & données · The Motley Fool

Eli Lilly Just Raised Its 2026 Sales Forecast to as Much as $92 Billion. But Is Viking Therapeutics the Next Big Obesity Winner?

Publié par The Motley Fool · États-Unis il y a 56 min

Eli Lilly Just Raised Its 2026 Sales Forecast to as Much as $92 Billion. But Is Viking Therapeutics the Next Big Obesity Winner? — Eli Lilly Just Raised Its 2026 Sales Forecast to as Much as $92 Billion. But Is Viking Therapeutics the Next Big Obesity Winner? · The Motley Fool

Résumé détaillé

These drugmakers offer very different risk-reward profiles.

Lire l'article complet sur The Motley Fool Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.fool.com)

À lire aussi

Nvidia’s stock drops as the board reportedly prepares to remove CEO Jensen Huang

Here are the major earnings before the open Thursday

Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares (NASDAQ:XNDU) Issues Quarterly Earnings Results

Oil prices rise amid mixed messaging on Iran peace efforts, Hormuz ship attacks

Prediction markets tied to clinical trials and drug approvals draw lawmakers' ire

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030